TickerFactsScreenerDevelopers

Cardiff Oncology, Inc. (CRDF) — Operating Income

Annual figures by fiscal year, from SEC filings.

2011: -$2.98M2012: -$4.85M2013: -$10.69M2014: -$14.95M2015: -$25.27M2016: -$40.15M2017: -$25.60M2018: -$17.05M2019: -$16.68M2020: -$19.09M2021: -$28.86M2022: -$39.90M2023: -$45.41M2024: -$48.65M2025: -$48.96M-$48.96M
2011Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$48.96M-0.6%
2024-$48.65M-7.1%
2023-$45.41M-13.8%
2022-$39.90M-38.3%
2021-$28.86M-51.2%
2020-$19.09M-14.4%
2019-$16.68M+2.2%
2018-$17.05M+33.4%
2017-$25.60M+36.2%
2016-$40.15M-58.8%
2015-$25.27M-69.1%
2014-$14.95M-39.8%
2013-$10.69M-120.5%
2012-$4.85M-62.9%
2011-$2.98M—